These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 7678576)

  • 1. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
    Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
    Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
    Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
    Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
    Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
    N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
    Melia WM; Johnson PJ; Neuberger J; Zaman S; Portmann BC; Williams R
    Gastroenterology; 1984 Sep; 87(3):660-3. PubMed ID: 6204905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
    Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
    Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
    Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed immune function in patients with cirrhosis before emergence of hepatocellular carcinoma.
    Saibara T; Maeda T; Miyazaki M; Onishi S; Yamamoto Y
    Hepatology; 1993 Aug; 18(2):315-9. PubMed ID: 7687981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study.
    Izuno K; Fujiyama S; Yamasaki K; Sato M; Sato T
    Hepatogastroenterology; 1995; 42(4):387-93. PubMed ID: 8586374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
    Mita Y; Aoyagi Y; Suda T; Asakura H
    J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Echographic detection of hepatocellular carcinoma in patients hospitalized for cirrhosis].
    Roget L; Coppéré H; Richard P; Barthélém C; Veyret C; Audigier JC
    Gastroenterol Clin Biol; 1988 Nov; 12(11):827-32. PubMed ID: 2464520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.
    Peng SY; Lai PL; Chu JS; Lee PH; Tsung PT; Chen DS; Hsu HC
    Hepatology; 1993 Jan; 17(1):35-41. PubMed ID: 7678574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
    Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
    BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
    Teofănescu I; Gologan E; Stefănescu G; Bălan G
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.